Mounting studies reported that ODC1 expression was increased in many cancers, such as esophageal carcinoma (55), colorectal cancer (56), hepatocellular carcinoma (57), neuroblastoma (58), and ovarian cancer (59). Here, ODC1 is linked to hepatocellular carcinoma.